Abstract

Urticarial rash is a hallmark symptom of autoinflammatory diseases such as Cryopyrin-associated periodic syndrome (CAPS) and Schnitzler's syndrome (SchS). Clinically, the urticarial rash may not be distinguished from the skin symptoms in chronic urticaria patients. As interleukin-1s (IL-1s) has been shown to play a pivotal role in the pathogenesis of CAPS and SchS we here aim at investigating IL-1s and related cytokines for their potential as diagnostic skin biomarkers in patients with urticarial autoinflammatory syndromes.

Highlights

  • Urticarial rash is a hallmark symptom of autoinflammatory diseases such as Cryopyrin-associated periodic syndrome (CAPS) and Schnitzler’s syndrome (SchS)

  • The urticarial rash may not be distinguished from the skin symptoms in chronic urticaria patients

  • Submit your manuscript to BioMed Central and take full advantage of:

Read more

Summary

Introduction

Urticarial rash is a hallmark symptom of autoinflammatory diseases such as Cryopyrin-associated periodic syndrome (CAPS) and Schnitzler’s syndrome (SchS). The urticarial rash may not be distinguished from the skin symptoms in chronic urticaria patients. As interleukin-1ß (IL-1ß) has been shown to play a pivotal role in the pathogenesis of CAPS and SchS we here aim at investigating IL-1ß and related cytokines for their potential as diagnostic skin biomarkers in patients with urticarial autoinflammatory syndromes

Conclusion
Materials and methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.